These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Quantitative justification for target concentration intervention--parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Matthews I; Kirkpatrick C; Holford N Br J Clin Pharmacol; 2004 Jul; 58(1):8-19. PubMed ID: 15206987 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of the new antiarrhythmic agent restacorin in patients with normal and decreased left ventricular function. Tuininga YS; Crijns HJ; Oosterhuis B; Wiesfeld AC; van Wijk LM; Albronda F; de Bruin H; Jonkman JH; Kozma C; Lie KI J Cardiovasc Pharmacol; 1994 Mar; 23(3):408-14. PubMed ID: 7515984 [TBL] [Abstract][Full Text] [Related]
26. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis. Lugo G; Castañeda-Hernández G Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600 [TBL] [Abstract][Full Text] [Related]
27. Variability in aminoglycoside pharmacokinetics in critically ill surgical patients. Dasta JF; Armstrong DK Crit Care Med; 1988 Apr; 16(4):327-30. PubMed ID: 3349791 [TBL] [Abstract][Full Text] [Related]
28. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778 [TBL] [Abstract][Full Text] [Related]
29. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients. Zarowitz BJ; Robert S; Peterson EL Ann Pharmacother; 1992 Oct; 26(10):1205-10. PubMed ID: 1421639 [TBL] [Abstract][Full Text] [Related]
30. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients. Mueller EW; Boucher BA Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611 [TBL] [Abstract][Full Text] [Related]
32. Recommended dose of arbekacin, an aminoglycoside against methicillin-resistant Staphylococcus aureus, does not achieve desired serum concentration in critically ill patients with lowered creatinine clearance. Fukuoka N; Aibiki M J Clin Pharm Ther; 2008 Oct; 33(5):521-7. PubMed ID: 18834367 [TBL] [Abstract][Full Text] [Related]
33. Predicting need for pharmacokinetic consultation follow-up using discriminant analysis. Beck DE; Bradley EL; Farringer JA Clin Pharm; 1988 Sep; 7(9):681-8. PubMed ID: 3240660 [TBL] [Abstract][Full Text] [Related]
34. Aminoglycoside pharmacokinetics in African-Americans with normal renal function. Oparaoji EC; Siram S; Elemihe U; Mezghebe HM; Cho T; Bashiri M; Piedrahita K; Pipalla RS J Clin Pharm Ther; 1998 Jun; 23(3):191-7. PubMed ID: 9831970 [TBL] [Abstract][Full Text] [Related]
35. Correlations between aminoglycoside pharmacokinetic parameters and patient's factors: from statement to implication for individual dosage design. Firsov AA; Nasonov VN Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():327-31. PubMed ID: 1820904 [TBL] [Abstract][Full Text] [Related]
36. External validation of aminoglycoside models used in web calculators and clinical decision support systems after laboratory conversion to serum creatinine isotope dilution mass spectrometry assay. Wolowich WR; Steinberg JG Clin Ther; 2012 Apr; 34(4):803-10. PubMed ID: 22421578 [TBL] [Abstract][Full Text] [Related]
37. Validation of the Hartford nomogram in trauma surgery patients. Finnell DL; Davis GA; Cropp CD; Ensom MH Ann Pharmacother; 1998 Apr; 32(4):417-21. PubMed ID: 9562135 [TBL] [Abstract][Full Text] [Related]
38. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients. Hickling KG; Begg EJ; Perry RE; Atkinson HC; Sharman JR Crit Care Med; 1991 Aug; 19(8):1041-7. PubMed ID: 1860329 [TBL] [Abstract][Full Text] [Related]
39. Optimizing Aminoglycoside Dosing Regimens for Critically Ill Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches. Avedissian SN; Rohani R; Bradley J; Le J; Rhodes NJ Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33526481 [TBL] [Abstract][Full Text] [Related]
40. [Factors affecting the pharmacokinetics of aminoglycoside antibiotics]. Dyderski S Wiad Lek; 1989 Jul 1-15; 42(13-15):919-23. PubMed ID: 2634321 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]